Latest Breast cancer treatment Stories
To Begin I-124-CLR1404 (LIGHT) Phase 2 Imaging Trial in Brain Cancer in Early 2014 MADISON, Wis., May 16, 2013 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today provided an update on its product pipeline, including I-124-CLR1404 (LIGHT) positron emission tomography (PET) imaging agent for solid tumor indications, I-131-CLR1404 (HOT) cancer-targeted molecular...
A new study published in The Oncologist shows targeting both hormone receptors (HRs) and human epidermal growth factor receptor 2 (HER2) in first-line treatment of metastatic breast cancer (MBC) patients significantly increased overall survival times. Durham, NC (PRWEB) May 07, 2013 A new study published in The Oncologist shows targeting both hormone receptors (HRs) and human epidermal growth factor receptor 2 (HER2) in first-line treatment of metastatic breast cancer (MBC) patients...
Cianna Medical, Inc.: Researchers from 12 sites report favorably low recurrence rates and minimal toxicities. CHICAGO (PRWEB) May 02, 2013 Strut-based breast brachytherapy – a form of radiation therapy for early-stage breast cancer – has been shown to be a well-tolerated, effective treatment, according to a scientific poster presentation at the 2013 annual meeting of the American Society of Breast Surgeons (ASBrS) in Chicago, May 1-5, 2013. The...
Revenues Continue to Ramp in 2013 IRVINE, Calif., May 2, 2013 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that it has reported more than 20,000 MammaPrint breast cancer results, including approximately 6,000 in 2012 alone. The MammaPrint test analyzes 70 key genes and accurately determines which patients are at low risk of breast cancer recurrence and can therefore safely choose not to undergo chemotherapy. Case volume grew by more than...
Two large, landmark radiotherapy studies have shown that it is possible to treat cervical cancer effectively with high doses specifically adapted to each tumor, and with fewer serious side-effects to the surrounding normal organs. In two presentations today (Saturday) and tomorrow (Sunday) researchers will tell the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO) that image-guided brachytherapy is able to deliver very high doses, which prevent the tumor from growing...
Mathematical prediction models are better than doctors at predicting the outcomes and responses of lung cancer patients to treatment, according to new research presented today (Saturday) at the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO). These differences apply even after the doctor has seen the patient, which can provide extra information, and knows what the treatment plan and radiation dose will be. "The number of treatment options available for lung...
redOrbit Staff & Wire Reports - Your Universe Online Treating early breast cancer patients with an advanced form of radiotherapy known as IMRT could reduce the side effects those women experience, according to the results of a randomized trial presented Sunday during the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO) in Geneva, Switzerland. IMRT (intensity modulated radiotherapy) is a high-precision form of treatment that delivers an even dose of radiation,...
redOrbit Staff & Wire Reports - Your Universe Online Two landmark radiotherapy studies demonstrating cervical cancer tumors can be effectively treated with specifically-adapted high doses will be presented this weekend at the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO). The studies, which will be presented over the next two days at the conference in Geneva, Switzerland, demonstrate image-guided brachytherapy was able to deliver extremely high doses that...
Research suggests 'chemo brain' may involve neurophysiological change For many years, breast cancer patients have reported experiencing difficulties with memory, concentration and other cognitive functions following cancer treatment. Whether this mental "fogginess" is psychosomatic or reflects underlying changes in brain function has been a bone of contention among scientists and physicians. Now, a new study led by Dr. Patricia Ganz, director of cancer prevention and control research at...
Cianna Medical, Inc: Recent studies conclude breast brachytherapy with the SAVI applicator appears to be a well-tolerated, effective treatment for early-stage breast cancer. New Orleans, Louisiana (PRWEB) April 18, 2013 Breast brachytherapy with a strut-based applicator demonstrated low recurrence rates and minimal toxicities, according to a multi-site study with a median follow-up of four years. The research was presented at the annual meeting of the American Brachytherapy Society, held...
